Literature DB >> 2481432

Globular changes in cytomegaloviral inclusions after Ganciclovir treatment.

Z Hruban1, R Kuzo, P Heimann, E Weisenberg, R H Hruban.   

Abstract

Ganciclovir treatment induced eosinophilic intranuclear globules and loss of DNA staining in pulmonary CMV-infected cells. Nuclear capsids contained ring-shaped cores. Cytoplasmic vacuoles contained altered, enveloped, mostly coreless viral particles.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481432     DOI： 10.1007/bf01310941

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  12 in total

1.  HUMAN CYTOMEGALOVIRUS INFECTION. ELECTRON MICROSCOPIC AND HISTOCHEMICAL CHANGES IN CULTURES OF HUMAN FIBROBLASTS.

Authors:  B H RUEBNER; T HIRANO; R J SLUSSER; D N MEDEARIS
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

Review 2.  Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections?

Authors:  R J Whitley
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

3.  Cytomegalovirus: the relationship of nucleocapsid assembly to the organization of cellulae.

Authors:  M Fons; T Albrecht
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. I. Sequence of viral replication.

Authors:  J D Smith; E De Harven
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

5.  Cellular responses to human cytomegalovirus infection.

Authors:  T Albrecht; J L Li; D Speelman; R Ball; M Nokta; M Fons; C H Lee; O Steinsland; W C Thompson; D H Carney
Journal:  Birth Defects Orig Artic Ser       Date:  1984

Review 6.  Evolution of therapy for cytomegalovirus infection.

Authors:  J P Verheyden
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.

Authors:  W C Buhles; B J Mastre; A J Tinker; V Strand; S H Koretz
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

8.  Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection.

Authors:  C V Paya; P E Hermans; T F Smith; J Rakela; R H Wiesner; R A Krom; V E Torres; S Sterioff; C J Wilkowske
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

Review 9.  Management of cytomegalovirus infection.

Authors:  J D Meyers
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

10.  Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients.

Authors:  M A Harbison; P C De Girolami; R L Jenkins; S M Hammer
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.